Mutagenicity of carcinogenic nitrosamines when activated by hamster and human pancreatic duct epithelial cells

Carol Kolar, Terence A Lawson

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We have measured the ability of pancreatic duct epithelial cells (DEC) from Syrian hamsters and humans and CK cells, immortalized hamster DEC, to metabolize chemical carcinogens to species that were mutagenic in S. typhimurium TA98 and in V79 cells. The chemicals were N-nitrosobis(2-oxopropyl)amine (BOP), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). The ability of ethanol (EtOH) to modify the metabolizing efficiency was also measured. When an S9 preparation from EtOH-treated CK cells was used to metabolize NNK the number of revertants was 271 ± 73 compared with 17 ± 2 when the S9 from control CK cells was used. When hamster DEC were used there was no increase in the mutation frequency for BOP in V79 cells (64 ± 20 mutants/106 survivors per μmol) when EtOH-DEC were used. However, the mutation frequencies of NNK and PhIP rose when the EtOH-treated DEC were used from 62 ± 31 to 198 ± 28 mutants/106 survivors per μmol for NNK and from 94 ± 25 to 166 ± 25 mutants/106 survivors per μmol for PhIP. A similar result was obtained when human DEC were used, i.e. no change in BOP mutagenicity and a slight increase in PhIP mutagenicity, from 34 ± 14 to 65 ± 12 mutants/106 survivors per μmol. There were large increases in the mutagenicity of NNK with each of the three samples of human DEC that were used, from 75 ± 0 to 213 ± 38, 75 ± 13 to 175 ± 25 and 38 ± 13 to 285 ± 25 mutants/106 survivors per μmol. The EtOH treatment regimen that was used more closely mimicked chronic exposure at low concentrations in vivo. These data show that hamster DEC are capable of metabolizing NNK, which is carcinogenic in these cells in vivo. Furthermore, human DEC metabolized NNK as efficiently as hamster DEC.

Original languageEnglish (US)
Pages (from-to)149-154
Number of pages6
JournalCancer Letters
Volume117
Issue number2
DOIs
StatePublished - Aug 19 1997

Fingerprint

Nitrosamines
Pancreatic Ducts
Cricetinae
Epithelial Cells
nitrosobis(2-oxopropyl)amine
Mutation Rate
Mesocricetus
Carcinogens
Ethanol
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine

Keywords

  • Ethanol
  • Hamster
  • Human
  • Nitrosamines
  • Pancreatic duct epithelial cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Mutagenicity of carcinogenic nitrosamines when activated by hamster and human pancreatic duct epithelial cells. / Kolar, Carol; Lawson, Terence A.

In: Cancer Letters, Vol. 117, No. 2, 19.08.1997, p. 149-154.

Research output: Contribution to journalArticle

@article{9ebd04e1bb4844eb82a20d6c42ef51e4,
title = "Mutagenicity of carcinogenic nitrosamines when activated by hamster and human pancreatic duct epithelial cells",
abstract = "We have measured the ability of pancreatic duct epithelial cells (DEC) from Syrian hamsters and humans and CK cells, immortalized hamster DEC, to metabolize chemical carcinogens to species that were mutagenic in S. typhimurium TA98 and in V79 cells. The chemicals were N-nitrosobis(2-oxopropyl)amine (BOP), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). The ability of ethanol (EtOH) to modify the metabolizing efficiency was also measured. When an S9 preparation from EtOH-treated CK cells was used to metabolize NNK the number of revertants was 271 ± 73 compared with 17 ± 2 when the S9 from control CK cells was used. When hamster DEC were used there was no increase in the mutation frequency for BOP in V79 cells (64 ± 20 mutants/106 survivors per μmol) when EtOH-DEC were used. However, the mutation frequencies of NNK and PhIP rose when the EtOH-treated DEC were used from 62 ± 31 to 198 ± 28 mutants/106 survivors per μmol for NNK and from 94 ± 25 to 166 ± 25 mutants/106 survivors per μmol for PhIP. A similar result was obtained when human DEC were used, i.e. no change in BOP mutagenicity and a slight increase in PhIP mutagenicity, from 34 ± 14 to 65 ± 12 mutants/106 survivors per μmol. There were large increases in the mutagenicity of NNK with each of the three samples of human DEC that were used, from 75 ± 0 to 213 ± 38, 75 ± 13 to 175 ± 25 and 38 ± 13 to 285 ± 25 mutants/106 survivors per μmol. The EtOH treatment regimen that was used more closely mimicked chronic exposure at low concentrations in vivo. These data show that hamster DEC are capable of metabolizing NNK, which is carcinogenic in these cells in vivo. Furthermore, human DEC metabolized NNK as efficiently as hamster DEC.",
keywords = "Ethanol, Hamster, Human, Nitrosamines, Pancreatic duct epithelial cells",
author = "Carol Kolar and Lawson, {Terence A}",
year = "1997",
month = "8",
day = "19",
doi = "10.1016/S0304-3835(97)00226-7",
language = "English (US)",
volume = "117",
pages = "149--154",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Mutagenicity of carcinogenic nitrosamines when activated by hamster and human pancreatic duct epithelial cells

AU - Kolar, Carol

AU - Lawson, Terence A

PY - 1997/8/19

Y1 - 1997/8/19

N2 - We have measured the ability of pancreatic duct epithelial cells (DEC) from Syrian hamsters and humans and CK cells, immortalized hamster DEC, to metabolize chemical carcinogens to species that were mutagenic in S. typhimurium TA98 and in V79 cells. The chemicals were N-nitrosobis(2-oxopropyl)amine (BOP), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). The ability of ethanol (EtOH) to modify the metabolizing efficiency was also measured. When an S9 preparation from EtOH-treated CK cells was used to metabolize NNK the number of revertants was 271 ± 73 compared with 17 ± 2 when the S9 from control CK cells was used. When hamster DEC were used there was no increase in the mutation frequency for BOP in V79 cells (64 ± 20 mutants/106 survivors per μmol) when EtOH-DEC were used. However, the mutation frequencies of NNK and PhIP rose when the EtOH-treated DEC were used from 62 ± 31 to 198 ± 28 mutants/106 survivors per μmol for NNK and from 94 ± 25 to 166 ± 25 mutants/106 survivors per μmol for PhIP. A similar result was obtained when human DEC were used, i.e. no change in BOP mutagenicity and a slight increase in PhIP mutagenicity, from 34 ± 14 to 65 ± 12 mutants/106 survivors per μmol. There were large increases in the mutagenicity of NNK with each of the three samples of human DEC that were used, from 75 ± 0 to 213 ± 38, 75 ± 13 to 175 ± 25 and 38 ± 13 to 285 ± 25 mutants/106 survivors per μmol. The EtOH treatment regimen that was used more closely mimicked chronic exposure at low concentrations in vivo. These data show that hamster DEC are capable of metabolizing NNK, which is carcinogenic in these cells in vivo. Furthermore, human DEC metabolized NNK as efficiently as hamster DEC.

AB - We have measured the ability of pancreatic duct epithelial cells (DEC) from Syrian hamsters and humans and CK cells, immortalized hamster DEC, to metabolize chemical carcinogens to species that were mutagenic in S. typhimurium TA98 and in V79 cells. The chemicals were N-nitrosobis(2-oxopropyl)amine (BOP), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). The ability of ethanol (EtOH) to modify the metabolizing efficiency was also measured. When an S9 preparation from EtOH-treated CK cells was used to metabolize NNK the number of revertants was 271 ± 73 compared with 17 ± 2 when the S9 from control CK cells was used. When hamster DEC were used there was no increase in the mutation frequency for BOP in V79 cells (64 ± 20 mutants/106 survivors per μmol) when EtOH-DEC were used. However, the mutation frequencies of NNK and PhIP rose when the EtOH-treated DEC were used from 62 ± 31 to 198 ± 28 mutants/106 survivors per μmol for NNK and from 94 ± 25 to 166 ± 25 mutants/106 survivors per μmol for PhIP. A similar result was obtained when human DEC were used, i.e. no change in BOP mutagenicity and a slight increase in PhIP mutagenicity, from 34 ± 14 to 65 ± 12 mutants/106 survivors per μmol. There were large increases in the mutagenicity of NNK with each of the three samples of human DEC that were used, from 75 ± 0 to 213 ± 38, 75 ± 13 to 175 ± 25 and 38 ± 13 to 285 ± 25 mutants/106 survivors per μmol. The EtOH treatment regimen that was used more closely mimicked chronic exposure at low concentrations in vivo. These data show that hamster DEC are capable of metabolizing NNK, which is carcinogenic in these cells in vivo. Furthermore, human DEC metabolized NNK as efficiently as hamster DEC.

KW - Ethanol

KW - Hamster

KW - Human

KW - Nitrosamines

KW - Pancreatic duct epithelial cells

UR - http://www.scopus.com/inward/record.url?scp=0030824713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030824713&partnerID=8YFLogxK

U2 - 10.1016/S0304-3835(97)00226-7

DO - 10.1016/S0304-3835(97)00226-7

M3 - Article

VL - 117

SP - 149

EP - 154

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -